ChengDa Pharmaceuticals Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Market Capitalization	5,106	6,165	3,057	3,934	4,912	-
Market Cap Growth	59.46%	101.69%	-22.31%	-19.91%	-	-
Enterprise Value	4,204	5,243	1,875	2,523	3,463	-
Last Close Price	33.71	40.70	20.00	24.93	30.90	-
PE Ratio	-	-	-	43.24	46.13	-
PS Ratio	11.14	15.17	9.18	9.50	11.94	-
PB Ratio	2.43	2.94	1.43	1.73	2.22	-
P/TBV Ratio	2.47	3.00	1.45	1.75	2.25	-
P/OCF Ratio	112.06	181.22	106.70	20.48	103.06	-
EV/Sales Ratio	9.17	12.90	5.63	6.09	8.42	-
EV/EBITDA Ratio	59.56	98.23	-	25.67	32.80	-
EV/EBIT Ratio	-	-	-	43.75	49.28	-
Debt / Equity Ratio	0.02	0.03	0.04	-	-	0.13
Debt / EBITDA Ratio	0.63	1.11	-	-	-	0.48
Net Debt / Equity Ratio	-0.44	-0.45	-0.49	-0.60	-0.62	0.10
Net Debt / EBITDA Ratio	-13.03	-17.55	48.35	-13.88	-13.08	0.36
Net Debt / FCF Ratio	72.86	26.76	4.10	41.84	8.74	-0.91
Asset Turnover	0.19	0.17	0.14	0.17	0.27	0.68
Inventory Turnover	2.30	1.90	1.56	1.67	1.75	2.66
Quick Ratio	6.44	5.46	5.97	8.69	14.99	0.76
Current Ratio	7.57	6.43	6.84	9.58	16.88	1.53
Return on Equity (ROE)	-0.17%	-0.56%	-1.25%	4.05%	7.75%	20.28%
Return on Assets (ROA)	-0.22%	-0.50%	-1.76%	1.51%	2.92%	11.51%
Return on Invested Capital (ROIC)	-0.70%	-1.70%	-6.62%	5.76%	8.80%	19.45%
Return on Capital Employed (ROCE)	-0.40%	-0.90%	-3.10%	2.50%	3.20%	20.90%
Earnings Yield	-0.07%	-0.19%	-0.92%	2.31%	2.17%	-
FCF Yield	-0.25%	-0.57%	-8.43%	-0.83%	-3.22%	-
Dividend Yield	0.58%	0.49%	1.00%	0.80%	0.61%	-
Payout Ratio	-	-	-	31.89%	41.12%	31.20%
Buyback Yield / Dilution	0.19%	0.30%	1.75%	-2.12%	-30.56%	0.00%
Total Shareholder Return	0.77%	0.79%	2.75%	-1.32%	-29.96%	0.00%